Yuksel, M. K. Et Al. 2019. Evaluation of the association of SNP in carboxylesterase enzyme (CES1) with pharmacokinetic and adverse effects of capecitabine in breast and colorectal cancer patients. ISTANBUL JOURNAL OF PHARMACY , vol.49, no.2 , 64-69.

Yuksel, M. K., ÖZTÜRK, D., Oztas, E., Ozhan, G., Turker, A. A., KORKMAZ, T., ... Okyar, A.(2019). Evaluation of the association of SNP in carboxylesterase enzyme (CES1) with pharmacokinetic and adverse effects of capecitabine in breast and colorectal cancer patients. ISTANBUL JOURNAL OF PHARMACY , vol.49, no.2, 64-69.

Yuksel, Merve Et Al. "Evaluation of the association of SNP in carboxylesterase enzyme (CES1) with pharmacokinetic and adverse effects of capecitabine in breast and colorectal cancer patients," ISTANBUL JOURNAL OF PHARMACY , vol.49, no.2, 64-69, 2019

Yuksel, Merve K. Et Al. "Evaluation of the association of SNP in carboxylesterase enzyme (CES1) with pharmacokinetic and adverse effects of capecitabine in breast and colorectal cancer patients." ISTANBUL JOURNAL OF PHARMACY , vol.49, no.2, pp.64-69, 2019

Yuksel, M. K. Et Al. (2019) . "Evaluation of the association of SNP in carboxylesterase enzyme (CES1) with pharmacokinetic and adverse effects of capecitabine in breast and colorectal cancer patients." ISTANBUL JOURNAL OF PHARMACY , vol.49, no.2, pp.64-69.

@article{article, author={Merve Kurtan Yuksel Et Al. }, title={Evaluation of the association of SNP in carboxylesterase enzyme (CES1) with pharmacokinetic and adverse effects of capecitabine in breast and colorectal cancer patients}, journal={ISTANBUL JOURNAL OF PHARMACY}, year=2019, pages={64-69} }